Aojing Medical (688613.SH) announced that the company received a notification letter from the original shareholder Cowin China Growth Fund I, LP (Cowin China Growth Fund Phase I Partnership) on July 5, During the period from May 23 to May 30, 2022, it reduced its holdings of the company’s shares by a total of 1.323 million shares through block transactions, and the number of shares reduced accounted for 0.9922% of the company’s total share capital. From July 1 to July 4, 2022 During the day, a total of 120,000 shares of the company were reduced through centralized bidding, and the number of shares reduced accounted for 0.09% of the company’s total share capital. After this equity change, its shareholding ratio decreased from 5.5678% to 4.4856%.
Massive information, accurate interpretation, all in Sina Finance APP